Only One Place to Go for In-sourcing Challenge
Client Alert | less than 1 min read | 04.14.14
In Fisher-Cal Indus., Inc. v. U.S. (Apr. 8, 2014), the D.C. Circuit bounced an incumbent's challenge to the agency's in-sourcing decision. Finding the decision to be part of the procurement process, the court ruled that it was, in essence, a bid protest that could be brought only in the Court of Federal Claims.
Insights
Client Alert | 4 min read | 01.07.26
On December 17, 2025, the U.S. Food and Drug Administration (FDA) issued a request for information (RFI) on a proposal designed to help the FDA engage more directly with innovative, venture-backed companies focused on biotechnology, medical devices, AI, and regulatory technology.[i]The RFI includes 19 questions, with responses due by 2:00 p.m. ET on January 18, 2026.
Client Alert | 3 min read | 01.07.26
CMMC for AI? Defense Policy Law Imposes AI Security Framework and Requirements on Contractors
Client Alert | 3 min read | 01.07.26
New Year, Same CIPA Uncertainty – When Will the Appellate Courts Enter the Chat?
Client Alert | 11 min read | 01.07.26
